药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Hydroxytestosterone
Carisbamate
The risk or severity of adverse effects can be increased when Lemborexant is combined with Carisbamate.
4-Hydroxytestosterone
Salvinorin A
The risk or severity of adverse effects can be increased when Lemborexant is combined with Salvinorin A.
4-Hydroxytestosterone
Eltanolone
The risk or severity of adverse effects can be increased when Lemborexant is combined with Eltanolone.
4-Hydroxytestosterone
Ecopipam
The risk or severity of adverse effects can be increased when Lemborexant is combined with Ecopipam.
4-Hydroxytestosterone
Cerlapirdine
The risk or severity of adverse effects can be increased when Lemborexant is combined with Cerlapirdine.
4-Hydroxytestosterone
Gepirone
The risk or severity of adverse effects can be increased when Lemborexant is combined with Gepirone.
4-Hydroxytestosterone
Eplivanserin
The risk or severity of adverse effects can be increased when Lemborexant is combined with Eplivanserin.
4-Hydroxytestosterone
Sarpogrelate
The risk or severity of adverse effects can be increased when Lemborexant is combined with Sarpogrelate.
4-Hydroxytestosterone
Vinpocetine
The risk or severity of adverse effects can be increased when Lemborexant is combined with Vinpocetine.
4-Hydroxytestosterone
MK-212
The risk or severity of adverse effects can be increased when Lemborexant is combined with MK-212.
4-Hydroxytestosterone
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when Lemborexant is combined with m-Chlorophenylpiperazine.
4-Hydroxytestosterone
Imagabalin
The risk or severity of adverse effects can be increased when Lemborexant is combined with Imagabalin.
4-Hydroxytestosterone
Tetrahydropalmatine
The risk or severity of adverse effects can be increased when Lemborexant is combined with Tetrahydropalmatine.
4-Hydroxytestosterone
Vabicaserin
The risk or severity of adverse effects can be increased when Lemborexant is combined with Vabicaserin.
4-Hydroxytestosterone
Idalopirdine
The risk or severity of adverse effects can be increased when Lemborexant is combined with Idalopirdine.
4-Hydroxytestosterone
Lanicemine
The risk or severity of adverse effects can be increased when Lanicemine is combined with Lemborexant.
4-Hydroxytestosterone
Etiracetam
The risk or severity of adverse effects can be increased when Etiracetam is combined with Lemborexant.
4-Hydroxytestosterone
Brexanolone
The risk or severity of adverse effects can be increased when Brexanolone is combined with Lemborexant.
4-Hydroxytestosterone
Tetrahydrocannabivarin
The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Lemborexant.
4-Hydroxytestosterone
Tropisetron
The risk or severity of adverse effects can be increased when Tropisetron is combined with Lemborexant.